“schizophrenia” Archives

in
Entry Author Date Location
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
From One Japanese Backer to Another: Galenea Advances Brain Drugs 07/19/12 Boston
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
EnVivo Posts Positive Trial of Schizophrenia Drug 12/05/11 Boston
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases 10/18/11 Boston
Stealthy Karuna Licenses Schizophrenia Drugs from Vanderbilt 09/28/11 Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s 07/25/11 Boston
Zogenix Strategy Unfolds as it Unveils Plans for Next Drug-and-Device Combo 07/19/11 San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” 07/06/11 Boston
Alkermes Acquires Elan Drug Manufacturing Unit for $960M 05/09/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Ex-Pfizer Exec Ed Harrigan Takes Top Job at Secretive Karuna Pharmaceuticals 01/20/11 Boston
Allon Starts Trial for Brain Disease 01/06/11 Seattle
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Allon Therapeutics Adds $10M 11/01/10 Seattle
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
BrainCells Inc. Buys Neuro Drug 08/04/10 San Diego
Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug 04/26/10 Boston
Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug 04/06/10 Seattle
San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug 03/10/10 San Diego
AFraxis CEO Outlines Biotech’s Success With Ultra-Lean Pre-Clinical R&D in Russia 02/26/10 San Diego
NIH Chief Stresses Economic Impact of Federal Biomedical Funding 02/22/10 San Diego
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood 02/04/10 Boston
Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron 12/03/09 Boston
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/08/09 Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
FDA OKs Risperdal Consta for Bipolar 05/18/09 Boston
Page 2 of 3 « previous page · next page »